Published in Neurology on October 14, 2003
Reduced Purkinje cell number in essential tremor: a postmortem study. Arch Neurol (2008) 1.99
Association between essential tremor and other neurodegenerative diseases: what is the epidemiological evidence? Neuroepidemiology (2011) 1.70
The emerging neuropathology of essential tremor. Mov Disord (2008) 1.62
Familial associations of Alzheimer disease and essential tremor with Parkinson disease. Eur J Neurol (2010) 1.56
Replication of the LINGO1 gene association with essential tremor in a North American population. Eur J Hum Genet (2010) 1.32
Environmental epidemiology of essential tremor. Neuroepidemiology (2008) 1.11
Emergence of Parkinson's disease in essential tremor: a study of the clinical correlates in 53 patients. Mov Disord (2008) 1.05
Essential tremor: a neurodegenerative disease? Tremor Other Hyperkinet Mov (N Y) (2014) 1.03
Familial aggregation of Parkinson's disease in a multiethnic community-based case-control study. Mov Disord (2010) 0.91
The role of 123I-FP-CIT-SPECT in the differential diagnosis of Parkinson and tremor syndromes: a critical assessment of 125 cases. J Neurol (2011) 0.83
Mutations in the Parkinson's disease genes, Leucine Rich Repeat Kinase 2 (LRRK2) and Glucocerebrosidase (GBA), are not associated with essential tremor. Parkinsonism Relat Disord (2009) 0.81
Tremor-related quality of life: A comparison of essential tremor vs. Parkinson's disease patients. Parkinsonism Relat Disord (2015) 0.79
Assessment of movement time in patients with essential tremor. J Neurol (2005) 0.78
Legionnaires' disease: description of an epidemic of pneumonia. N Engl J Med (1977) 24.44
Updated research nosology for HIV-associated neurocognitive disorders. Neurology (2007) 16.18
Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature (1998) 15.24
Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med (2001) 9.51
The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics. JAMA (1998) 7.81
Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med (2009) 7.53
Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet (1996) 7.10
Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole. Neurology (1999) 6.03
Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology (2001) 5.98
Core assessment program for intracerebral transplantations (CAPIT). Mov Disord (1992) 5.51
Parkinson disease in twins: an etiologic study. JAMA (1999) 5.45
The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat Genet (1997) 5.39
Genetic analysis of idiopathic torsion dystonia in Ashkenazi Jews and their recent descent from a small founder population. Nat Genet (1995) 5.11
Ethical problems in the management of some severely handicapped children. J Med Ethics (1981) 5.04
Diagnosis of dementia in a heterogeneous population. Development of a neuropsychological paradigm-based diagnosis of dementia and quantified correction for the effects of education. Arch Neurol (1992) 4.63
Influence of leisure activity on the incidence of Alzheimer's disease. Neurology (2001) 4.49
Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology (2010) 4.06
Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease. Neurology (1995) 3.91
Validity and reliability of a rating scale for the primary torsion dystonias. Neurology (1985) 3.56
Huntington disease: clinical care and evaluation. Neurology (1979) 3.54
Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up. Am J Psychiatry (2000) 3.54
Precautionary principle stifles discovery. Nature (1999) 3.38
Neuropsychological detection and characterization of preclinical Alzheimer's disease. Neurology (1995) 3.37
"Goodbye Dolly?" The ethics of human cloning. J Med Ethics (1997) 3.23
Delayed-onset dystonia in patients with "static" encephalopathy. J Neurol Neurosurg Psychiatry (1980) 3.19
Field testing and comparative evaluation of rapid, visually read screening assays for antibody to human immunodeficiency virus. Lancet (1989) 3.18
Predicting time to nursing home care and death in individuals with Alzheimer disease. JAMA (1997) 3.17
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. Neurology (2012) 3.12
The role of radiotracer imaging in Parkinson disease. Neurology (2005) 3.02
The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993. Am J Epidemiol (1995) 3.00
Recent developments in molecular epidemiology: A study of the effects of environmental polycyclic aromatic hydrocarbons on birth outcomes in Poland. Am J Epidemiol (1998) 2.96
The Washington Heights-Inwood Genetic Study of Essential Tremor: methodologic issues in essential-tremor research. Neuroepidemiology (1997) 2.96
Determinants of late stage diagnosis of breast and cervical cancer: the impact of age, race, social class, and hospital type. Am J Public Health (1991) 2.90
Pilot association study of the beta-glucocerebrosidase N370S allele and Parkinson's disease in subjects of Jewish ethnicity. Mov Disord (2005) 2.88
DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology (2007) 2.86
Diagnostic guidelines in central nervous system Whipple's disease. Ann Neurol (1996) 2.86
Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome. Nat Genet (2001) 2.81
Amino acid-induced translation of TOP mRNAs is fully dependent on phosphatidylinositol 3-kinase-mediated signaling, is partially inhibited by rapamycin, and is independent of S6K1 and rpS6 phosphorylation. Mol Cell Biol (2001) 2.72
Clinical evaluation of idiopathic paroxysmal kinesigenic dyskinesia: new diagnostic criteria. Neurology (2004) 2.70
Hypercholesterolaemia in borderline hypothyroidism. Stage of premyxoedema. Lancet (1970) 2.62
An activating mutation of AKT2 and human hypoglycemia. Science (2011) 2.60
Increased risk for recurrent major depression in DYT1 dystonia mutation carriers. Neurology (2004) 2.59
Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation. Science (2001) 2.52
Human cloning and child welfare. J Med Ethics (1999) 2.49
The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease. Ann Neurol (1993) 2.48
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003. Vox Sang (2005) 2.47
Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease. Neurology (2007) 2.41
The DYT1 phenotype and guidelines for diagnostic testing. Neurology (2000) 2.39
Diagnostic accuracy of serological assays in pediatric inflammatory bowel disease. Gastroenterology (1998) 2.38
Incentive spirometry versus routine chest physiotherapy for prevention of pulmonary complications after abdominal surgery. Lancet (1991) 2.36
Intraoperative 'no go' donor hepatectomies in living donor liver transplantation. Am J Transplant (2010) 2.33
Nitrous oxide (Entonox) inhalation and tolerance of transrectal ultrasound guided prostate biopsy: a double-blind randomized controlled study. J Urol (2002) 2.32
Pharmacokinetics of theophylline in children with asthma. Pediatrics (1976) 2.31
Is cloning an attack on human dignity? Nature (1997) 2.30
Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study. Neurology (2012) 2.26
Relationship between theophylline concentration in plasma and saliva of man. Clin Pharmacol Ther (1974) 2.26
Frequency of LRRK2 mutations in early- and late-onset Parkinson disease. Neurology (2006) 2.25
Increased risk of Alzheimer's disease in mothers of adults with Down's syndrome. Lancet (1994) 2.24
Premorbid weight, body mass, and varsity athletics in ALS. Neurology (2002) 2.23
Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial. J Neurol Neurosurg Psychiatry (2008) 2.22
Idiopathic cervical dystonia: clinical characteristics. Mov Disord (1991) 2.21
Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia. Neurology (2004) 2.18
Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia. Ann Neurol (1997) 2.17
Incidence of and risk factors for HIV-associated distal sensory polyneuropathy. Neurology (2002) 2.17
Ankylosing hyperostosis. I. Clinical and radiological features. Ann Rheum Dis (1974) 2.17
Accuracy of family history data on Parkinson's disease. Neurology (2003) 2.15